Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen No Longer Exclusive Distributor of Blue Heron's Synthetic Genes

NEW YORK (GenomeWeb News) — Invitrogen said today it will now co-exclusively distribute Blue Heron Biotechnology’s custom synthesis genes worldwide, updating an alliance it penned last year that made it the exclusive distributor.
 
Terms of the revamped deal call for Invitrogen to continue to supply Blue Heron’s GeneMaker technology to its pharmaceutical and life sciences customers worldwide.
 
In the original agreement, disclosed in December 2006, Invitrogen said it made an undisclosed equity investment in Blue Heron in return for becoming its exclusive worldwide distributor. Invitrogen said at that time it was shifting away from its history as a provider of clones to becoming a synthetic gene provider.
 
Financial terms of the revamped agreement were not disclosed.
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.